AMGN compared with STRO: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

STROSutro Biopharma, Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

STROSutro Biopharma, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

AMGNAmgen Inc

479.11▲+3.87%

Mkt cap$249.4BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

STROSutro Biopharma, Inc.

9.49▼−0.25%

Regular sessionNov 4 '26

Mkt cap$157.7MRevenue$10MQ2 FY26Revenue$102MFY25

Compare

Regular sessionNov 4 '26

AMGNAmgen Inc

STROSutro Biopharma, Inc.

479.11▲+3.87%

Price

9.49▼−0.25%

$249.4B

Mkt cap

$157.7M

Q3 FY26$10.4B

Revenue

$10MQ2 FY26

FY25$36.8B

Revenue

$102MFY25

AMGN479.11▲+3.87%vsSTRO9.49▼−0.25%Regular sessionNov 4 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

STRO: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No shared counterparties.

Only STRO 16

—Stanfordunlistedsupplier

—Alemany Plazaunlistedsupplier

—Five Prime Therapeuticsunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

Jefferies

unlistedsupplier

12 more · STRO chain ›

Price

rebased to 0%

AMGN, solidSTRO, dashed